Patent AnalyticsExaminers
Rankings

Company or institution

HEALX LTD

13 applicationsfiled 2018 to 2025

Allowance rate
27%
−48 pts vs the USPTO range 10% to 57%
Rejections before allowance
n/a
Needs 5 decided cases; has 3
Months to first action
26.4 mo
+7.8 vs the USPTO
Needed an RCE
9%
−18 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations11 apps
A61P Therapeutic activity of compounds2 apps

Art units

16283 apps
16293 apps
16212 apps
16271 apps
OPET1 apps
16241 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19136354NITROXOLINE FOR USE IN THE TREATMENT OR PREVENTION OF A MALIGNANT PERIPHERAL NERVE …2025-06-06Pending00n/a
18710477TREATMENT OF PLEXIFORM NEUROFIBROMA WITH NITROXOLINE2024-05-15Allowed1023.8 mo
18567829NITROXOLINE FOR USE IN THE TREATMENT OF CUTANEOUS NEUROFIBROMA2023-12-07Pending1029.1 mo
15395501Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15504877Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15212497Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15915799Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15778719Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15940957Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15627905Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 13 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in